New Brain Drug Combo Triggers Cancer Cell Death in Deadly Glioblastoma Tumors
Scientists develop brain-penetrating drug that makes glioblastoma cells vulnerable to targeted elimination therapy.
Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
320 articles
Scientists develop brain-penetrating drug that makes glioblastoma cells vulnerable to targeted elimination therapy.
Smaller cancer cells with doubled genomes show enhanced fitness and worse patient outcomes, revealing new prognostic markers.
Lactobacillus johnsonii bacteria enhances immune response and prevents liver cancer recurrence when combined with immunotherapy.
New research reveals how nasopharyngeal cancer cells rewire their metabolism to survive chemotherapy, pointing to potential treatment strategies.
New research reveals how breast cancer cells exploit fatty acids in lung tissue to enhance survival and metastasis.
New research reveals how a common gut bacterium reprograms immune cells to accelerate colorectal cancer progression.
Scientists discover LRRC15 protein controls cancer-promoting cells, offering new therapeutic approach for lung cancer patients.
Researchers found cancer cells use JAK1 protein to survive radiation therapy, but targeting KIF18A protein can overcome this resistance.
New research reveals how deadly thyroid cancer reprograms itself to escape natural killer cells, opening doors for better treatments.
New research reveals how osteosarcoma cells manipulate RNA stability to maintain aggressive growth and resist chemotherapy.
Study expands treatment options by demonstrating olaparib effectiveness in patients with PALB2 and somatic BRCA mutations.
Major trial reveals blood clot risks vary significantly between different pancreatic cancer treatment approaches.